Skip to main content
logo
Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1818
+0.0057 (3.24%)
At close: Aug 11, 2026, 4:00 PM EDT
0.1815
-0.0003 (-0.17%)
After-hours: Aug 11, 2026, 6:44 PM EDT

Gossamer Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
55.5448.47114.7---
Revenue Growth
-55.42%-57.74%----
Gross Profit
55.5448.47114.7---
Operating Income
-217.55-170.73-59.92-183.76-218.59-216.12
Net Income
-218.67-170.37-56.53-179.82-229.38-234
Earnings Per Share
-0.79-0.75-0.25-1.18-2.71-3.13
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
99.22136.93294.52296.43255.68325.22
Total Debt
201.98201.97201.92209.16222.76182.34
Net Cash (Debt)
-102.76-65.0492.687.2632.92142.88
Net Cash Growth
--6.11%165.06%-76.96%-57.03%
Net Cash Per Share
-0.45-0.280.410.570.391.91

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-170.26-171.27-3.47-159.16-187.03-188.89
Capital Expenditures
-0.05-0.08---0.41-1.55
Free Cash Flow
-170.32-171.35-3.47-159.16-187.44-190.44
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-391.72%-352.23%-52.24%---
Pretax Margin
-68.91%-351.67%-48.50%---
Profit Margin
-393.74%-351.49%-49.28%---
FCF Margin
-306.67%-353.50%-3.02%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.5614.951.79---